Feedback / Questions
sonelokimab (M1095) - Avillion, MoonLake Immunotherap
https://www.manilatimes.net/2026/08/10/tmt-newswire/globenewswire/moonlake-announces-positive-topline-results-from-the-phase-3-izar-1-trial-of-sonelokimab-in-psoriatic-arthritis-demonstrating-significant-improvements-across-all-clinical-endpoints-and-reports-second-quarter-2026-financial-results/2401905
Aug 10, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next